25H-NBOMe explained

Iupac Name:2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Width:200px
Legal Br:F2
Legal Br Comment:[1]
Legal De:NpSG
Legal Uk:Class A
Cas Number:919797-16-3
Unii:RN5ZVN74Y9
Atc Prefix:none
Pubchem:39424372
Chemspiderid:25511924
C:18
H:23
N:1
O:3
Smiles:COC1=CC(=C(C=C1)OC)CCNCC2=CC=CC=C2OC
Stdinchi:1S/C18H23NO3/c1-20-16-8-9-18(22-3)14(12-16)10-11-19-13-15-6-4-5-7-17(15)21-2/h4-9,12,19H,10-11,13H2,1-3H3
Stdinchikey:RMLXCDMTGWSEOU-UHFFFAOYSA-N

25H-NBOMe (NBOMe-2C-H) is a derivative of the phenethylamine hallucinogen 2C-H, which acts as a highly potent full agonist for the human 5-HT2A receptor.[2]

Toxicity and harm potential

Emergency treatment

Legality

Sweden

The Riksdag added 25H-NBOMe to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of August 1, 2013, published by Medical Products Agency (MPA) in regulation LVFS 2013:15 listed as 25H-NBOMe, and 2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin.[3]

United Kingdom

See also

Notes and References

  1. Web site: Anvisa . Brazilian Health Regulatory Agency . 2023-07-24 . RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial . Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control. live . https://web.archive.org/web/20230827163149/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 . 2023-08-27 . 2023-08-27 . . pt-BR . 2023-07-25.
  2. Biochemical Pharmacology . Amy E, Katherine W, John R, Sonyoung K, Robert J, Aaron J . Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors . 10.1016/j.bcp.2018.09.024 . 30261175 . 6298744 . 158 . 27–34 . December 2018.
  3. Web site: Läkemedelsverkets föreskrifter - LVFS och HSLF-FS;Läkemedelsverket/Swedish Medical Products Agency. live. https://web.archive.org/web/20130928024035/http://www.lakemedelsverket.se/upload/lvfs/LVFS_2013-15.pdf . 2013-09-28 .